Geneticure receives $1M from Xcellerant Ventures to advance precision medicine and establish a new clinical lab in Arizona.
Amount Raised
$1 Million
Round Type
Series A
ScottsdaleBiotechnologyHealth CareInvestors
Description
Xcellerant Ventures announced a $1 million investment in Geneticure to support the company's growth in precision medicine. The funding will help establish a new clinical laboratory in Arizona, enhancing the state's biotech hub. Geneticure focuses on predictive testing for resistant hypertension treatments. This investment will accelerate commercial scaling and support clinical validation efforts.
Who to call at Geneticure, and when
A new round usually means Geneticure is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneticure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneticure, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneticure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansGeneticure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.